Delivery Order SPE2DR25D2009-SPE2DR26FJ4D2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $54,157.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The award, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $56,984.99 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on November 13, 2025, with completion targeted for November 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $13,829.05 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The award was made on July 15, 2025, with an ultimate completion date of July 16, 2025, and no set-aside designation was applied. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location, serving as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $95,172.85 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 26, 2025, with completion targeted for August 27, 2025. This competitive award, issued under firm fixed pricing terms, supports federal medical procurement needs through AmerisourceBergen's established supply chain. The contract specifies performance from the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $78,459.61 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a non-competitive, non-set-aside procurement for pharmaceutical supply to support federal medical needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $34,485.14 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) with a completion date of December 15, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $83,800.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves the federal medical supply chain...
- The Defense Logistics Agency awarded a delivery order valued at $5,199.39 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on October 28, 2025, with completion scheduled for October 29, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of pharmaceutical supply under the company's existing contract vehicle with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $4,558.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on December 10, 2025, with completion scheduled for December 11, 2025. The contract employs firm fixed-price terms and carries no set-aside designation, indicating competitive award to this pharmaceutical distributor. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical...
- The Defense Logistics Agency awarded a delivery order valued at $42,459.84 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on November 25, 2025, with completion expected by November 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The product will be delivered to the company's facility in...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ4D2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $28,198.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a firm fixed price and no set-aside designation. The award was issued on December 11, 2025, with an ultimate completion date of December 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through the DLA's medical supply chain. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.2k | 12/10/25 |